Study on the influence of potent inhibitors of neuronal nitric oxide synthase on the antinociceptive and anticonvulsant activity of benzodiazepines in mice

Polish Journal of Pharmacology

Volumn 55, Issue 2, 2003, Pages 193-201

  Fidecka, Sylwia ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

1 (2 trifluoromethylphenyl)imidazole (TRIM), 3 bromo 7 nitroindazole (3 Br 7 NI); Clonazepam; Diazepam; Mice; Nociception; Seizures

Indexed keywords

1 (2 TRIFLUOROMETHYLPHENYL)IMIDAZOLE; 3 BROMO 7 NITROINDAZOLE; ANTICONVULSIVE AGENT; ANTINOCICEPTIVE AGENT; ARGININE; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; DIAZEPAM; IMIDAZOLE DERIVATIVE; MORPHINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PENTETRAZOLE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DEATH; DOSE RESPONSE; DRUG ABSORPTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; MALE; MOUSE; NONHUMAN; PAIN; STATISTICAL ANALYSIS; TONIC SEIZURE; WRITHING TEST;

ANALGESICS; ANIMALS; ANTICONVULSANTS; CLONAZEPAM; DIAZEPAM; DRUG SYNERGISM; IMIDAZOLES; INDAZOLES; MALE; MICE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; PAIN; PAIN MEASUREMENT; PENTYLENETETRAZOLE; SEIZURES;

EID: 0037769849     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Alexander C.B., Ellmore T.M., Kokate T.G., Kirkby R.D.: Further studies on anti- and proconvulsant effects of inhibitors of nitric oxide synthase in rodents. Eur. J. Pharmacol., 1998, 344, 15-25.
2. Babbedge R.C., Bland-Ward P.A., Hart S.L., Moore P.K.: Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Brit. J. Pharmacol., 1993, 110, 225-228.
3. Babbedge R.C., Hart S.L., Moore P.K.: Anti-nociceptive activity of nitric oxide synthase inhibitors in the mouse: dissociation between the effect of L-NAME and L-NMMA. J. Pharm. Pharmacol., 1993, 45, 77-79.
4. Bland-Ward P.A., Moore P.K.: 7-Nitro indazole derivatives are potent inhibitors of brain, endothelium and inducible isoforms of nitric oxide synthase. Life Sci., 1995. 57, 131-135.
5. Borowicz K.K., Kleinrok Z., Czuczwar S.J.: 7-Nitro-indazole differentially affects the anticonvulsant activity of antiepileptic drugs against amygdala-kindled seizures in rats. Epilepsia, 2000, 41, 1112-1118.
6. Borowicz K.K., Łuszczki J., Kleinrok Z., Czuczwar S.J.: 7-Nitroindazole, a nitric oxide synthase inhibitor, enhances the anticonvulsive action of ethosuximide and clonazepam against pentylenetetrazol-induced convulsions. J. Neural Transm., 2000, 107, 1117-1126.
7. G-Nitro-L-arginine impairs the anticonvulsive action of ethosuximide against pentylenetetrazol. Eur. J. Pharmacol., 1999, 366, 137-142.
8. Dellemijn L.J., Fields H.L.: Do benzodiazepines have a role in chronic pain management? Pain, 1994, 57, 137-152.
9. De Sarro G., Di Paola E.D., De Sarro A., Vital M.J.: L-Arginine potentiates excitatory amino acid-induced seizures elicited in the deep prepiriform cortex. Eur. J. Pharmacol., 1993, 230, 151-158.
10. Desvignes C., Bert L., Vinet L., Denoroy L., Renaud B., Lambas-Senas L: Evidence that the neuronal nitric oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3,4-dihydroxyphenylacetic acid. Neurosci. Lett., 1999, 261, 175-178.
11. Duarte I.D.G., Lorenzetti B.P., Ferreira S.H.: Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur. J. Pharmacol., 1990, 186, 289-293.
12. Dzoljic E., De Vries R., Dzoljic M.R.: Anticonvulsant activity of new and potent inhibitors of nitric oxide synthase. Brain Res. Bull. 1997, 43, 191-195.
13. Eddy N.B., Touchberry C.F., Lieberman J.: Synthetic analgesics. I. Methadone isomers and derivatives. J. Pharmacol. Exp. Ther., 1950, 98, 121-137.
14. Fidecka S.: Role of nitric oxide in antinociceptive and anticonvulsant activity of benzodiazepines. Pol. J. Pharmacol., 2001, 53, Suppl., 121.
15. Fidecka S., Lalewicz S.: Studies on the antinociceptive effects of sodium nitroprusside and molsidomine in mice. Pol. J. Pharmacol., 1997, 49, 395-400.
16. A receptor. NeuroReport, 1998, 9, 1089-1092.
17. Handy R.L.C., Moore P.K.: Effects of selective inhibitors of neuronal nitric oxide synthase on carrageenan-induced mechanical and thermal hyperalgesia. Neuropharmacology, 1998, 37, 37-43.
18. Handy R.L.C., Wallace P., Gaffen Z.A., Whitehead K.J., Moore P.K.: The antinociceptive effect of 1-(2-trifluoromethylphenyl)imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse. Brit. J. Pharmacol., 1995, 116, 2349-2350.
19. ω-nitro-L-arginine on seizures induced by several drugs in mice. Pharmacol. Biochem. Behav., 1996, 53, 673-677.
20. Kirkby R.D., Carroll D.M., Grossmann A.B., Subramaniam S.: Factors determining proconvulsant and anticonvulsant effects of inhibitors of nitric oxide synthase in rodents. Epilepsy Res., 1996, 24, 91-100.
21. Kitto K.F., Haley J.E., Wilcox G.L.: Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci. Lett., 1992, 148, 1-5.
22. Koster R., Anderson M., De Beer E.J.: Acetic acid for analgesic screening. Fed. Proc., 1959, 18, 412.
23. Larson A.A., Kovacs K.J., Cooper J.C., Kitto K.F.: Transient changes in the synthesis of nitric oxide result in long-term as well as short-term changes in acetic acid-induced writhing in mice. Pain, 2000, 86, 103-111.
24. Le Bars D., Gozariu. M., Cadden S.M.: Animal models of nociception. Pharmacol. Rev., 2001, 53, 597-652.
25. Möhler H., Fritschy J.M., Rudolph U.: A new benzodiazepine pharmacology. J. Pharmacol. Exp. Ther., 2002, 300, 2-8.
26. Moncada S., Palmer R. M.J., Higgs E.A.: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 1991, 43, 109-142.
27. G-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Brit. J. Pharmacol., 1990, 99, 408-412.
28. Moore P.K., Handy R.L.C.: Selective inhibitors of neuronal nitric oxide synthase - is no NOS really good NOS for the nervous system? Trends Pharmacol. Sci., 1997, 18, 204-211.
29. G-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Brit. J. Pharmacol., 1991, 102, 198-202.
30. Osonoe K., Mori N., Suzuki K., Osonoe M.: Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats. Brain Res., 1994, 663, 338-340.
31. Penix L.P., Davis W., Subramaniam S.: Inhibition of NO synthase increases the severity of kainic acid-induced seizures in rodents. Epilepsy Res., 1994, 18, 177-184.
32. Przegalińiski E., Baran L., Siwanowicz J.: The role of nitric oxide in chemically- and electrically-induced seizures in mice. Neurosci. Lett., 1996, 217, 145-148.
33. Reddy S., Patt R.B.: The benzodiazepines as adjuvant analgesics. J. Pain Symptom Manage., 1994, 9, 510-514.
34. Rees D.D., Palmer R.M.J., Schultz R., Hodson H.F., Moncada S.: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Brit. J. Pharmacol., 1990, 101, 746-752.
35. Rho J.M., Sankar R.: The pharmacologic basis of anti-epileptic drug action. Epilepsia, 1999, 40, 1471-1483.
36. Robello M., Amico C., Bucossi G., Cupello A., Rapallino M.V., Thellung S.: Nitric oxide and GABA-A receptor function in the rat cerebral cortex and cerebellar granule cells. Neuroscience, 1996, 74, 99-105.
37. Rodgers R.J., Randall J.I.: Benzodiazepine ligands, nociception and "defeat" analgesia. Psychopharmacology, 1987, 91, 305-315.
38. Rosland J.H., Hunskaar S., Hole K.: The effect of diazepam on nociception in mice. Pharmacol. Toxicol., 1987, 61, 111-115.
39. Segovia G., Porras A., Mora F.: Effects of a nitric oxide donor on glutamate and GABA release in striatum and hippocampus of conscious rat. NeuroReport, 1994, 5, 1937-1940.
40. G-monomethyl-L-arginine, an inhibitor of nitric oxide synthase, increases extracellular GABA in the striatum of the freely moving rat. NeuroReport, 1995, 6, 1298-1300.
41. Sierralta F., Miranda H.F.: Analgesic effect of benzodiazepines and flumazenil. Gen. Pharmacol., 1992, 23, 739-742.
42. Talarek S., Fidecka S.: Nitric oxide and antiepileptic activity of benzodiazepines in mice. Pol. J. Pharmacol., 1998, 50, 177-178.
43. Talarek S., Fidecka S.: Role of nitric oxide in benzodiazepines-induced antinociception in mice. Pol. J. Pharmacol., 2000, 54, 27-34.
44. Talarek S., Fidecka S.: Role of nitric oxide in anticonvulsant effects of benzodiazepines in mice. Pol. J. Pharmacol., 2003, 55, 181-191.
45. Tutka P., Łuszczki J., Kleinrok Z., Arent K., Wielosz M.: Molsidomine enhances the protective activity of valproate against pentylenetetrazole-induced seizures in mice. J. Neural Transm., 2002, 109, 455-466.
46. Valtschanoff J.G., Weinberg R.J., Kharazia V.N., Schmidt H.H., Nakane M., Rustioni A.: Neurons in rat cerebral cortex that synthesize nitric oxide: NADPH diaphorase histochemistry, NOS immunocytochemistry, and colocalization with GABA. Neurosci. Lett., 1993, 157, 157-161.
47. Valtschanoff J.G., Weinberg R.J., Rustioni A., Schmidt H.H.H.W.: Nitric oxide synthase and GABA colocalize in lamina II of rat spinal cord. Neurosci. Lett., 1992, 148, 6-10.
48. Yan X.X., Jen L.S., Garey L.J.: NADPH-diaphorase-positive neurons in primate cerebral cortex colocalize with GABA and calcium-binding proteins. Cereb. Cortex, 1996, 6, 524-529.
49. Zambotti F., Zonta N., Tammiso R., Conci F., Hafner B., Zecca L., Ferrario P., Mantegazza P.: Effects of diazepam on nociception in rats. Naunyn-Schmied. Arch. Pharmacol., 1991, 344, 84-89.
50. Zarri I., Bucossi G., Cupello A., Rapallino M.V., Robello M.: Modulation by nitric oxide of rat brain GABA-A receptors. Neurosci. Lett., 1994, 180, 239-242.